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An investigation into the validity of utilising the CDRAD 2.0 phantom for optimisation 
studies in digital radiography  
Abstract 
Objectives: To determine if a relationship exists between low contrast detail (LCD) detectability 
using the CDRAD 2.0 phantom, visual measures of image quality (IQ) and simulated lesion 
visibility (LV) when performing digital chest radiography (CXR). 
Methods:  Using a range of acquisition parameters, a CDRAD 2.0 phantom was used to acquire a 
set of images with different levels of image quality.  LCD detectability using the CDRAD 2.0 
phantom, represented by an image quality figure inverse (IQFinv) metric, was determined using the 
phantom analyser software.  A Lungman chest phantom was loaded with two simulated lesions, 
of different sizes / placed in different locations, and was imaged using the same acquisition factors 
as the CDRAD phantom.  A relative visual grading analysis (VGA) was used by seven observers 
for IQ and LV evaluation of the Lungman images.  Correlations between IQFinv, IQ and LV were 
investigated. 
Results: Pearson’s correlation demonstrated a strong positive correlation (r=0.91; p<0.001) 
between the IQ and the IQFinv.  Spearman’s correlation showed a good positive correlation (r=0.79; 
p<0.001) and (r=0.68; p<0.001) between the IQFinv and the LV for the first lesion (left upper lobe) 
and the second lesion (right middle lobe), respectively. 
Conclusions:  From results presented in this study, the automated evaluation of LCD detectability 
using CDRAD 2.0 phantom is likely to be a suitable option for IQ and LV evaluation in digital 
CXR optimisation studies. 
Advances in knowledge: This research establishes the potential of the CDRAD 2.0 phantom in 
digital CXR optimisation studies. 
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1. Introduction 
An essential technical priority of any X-ray examination is the production of an image with 
sufficient quality to answer the clinical question.  Balanced against this is the requirement to avoid 
unnecessary radiation risk to the patient 1.Within national legislature, a key aim is to identify 
acquisition parameters which deliver acceptable image quality with the lowest radiation dose 
practicable 2. Methods for patient dose assessment are readily available but the approaches for 
image quality (IQ) assessment are more complex.  Observer performance methods, such as 
receiver operating characteristic (ROC) and visual grading analysis (VGA), are often utilised for 
evaluating clinical IQ in research studies 3–6. Nevertheless, they are difficult to implement for the 
purpose of evaluating IQ, within and between hospitals and to use ROC and VGA methods within 
routine quality assurance programmes would be time consuming and require a large number of 
images.  Physics contrast-detail (CD) phantoms, such CDRAD 2.0 phantom, are normally used in 
medical physics departments7 and have been widely used within the literature for optimisation 
studies and when comparing the performance of imaging systems 8–12. The CDRAD 2.0 phantom 
does have limitations, it has a uniform background which does not take into account the influence 
of anatomical noise arising when imaging human anatomy  13. The principle of this phantom is 
based on the Rose model which assumes that the quantum noise is the limiting factor which can 
influence image quality (LCD detection)14.  This assumption is true for the CDRAD 2.0 phantom, 
but it could be limited for several common clinical tasks in diagnostic radiology 13.Within clinical 
practice, the limiting factor for LCD detection performance is the anatomical background which 
is considered to be the most influential factor in CXR IQ rather than the quantum noise 15–17 .  As 
such, the validity of using the CDRAD 2.0 phantom for representing the chest region for IQ and 
LV evaluations, including optimisation studies is questionable and needs further investigation13.  
It would be extremely useful if this phantom could predict visual (perceptual) IQ and LV in the 
clinical setting since these parameters are more useful in optimisation studies, when undertaking 
routine quality assurance and also when evaluating and comparing IQ between systems. 
The aim of this study was to investigate the potential of using LCD detectability, using the CDRAD 
2.0 phantom, for digital CXR optimisation studies by investigating its correlation with IQ and LV. 
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2. Materials and Methods  
Image acquisition 
Two different phantoms were used in this study, 1) an anthropomorphic Lungman chest phantom 
(Kyoto Kagaku Co., Japan) 18, loaded with two spherical phantom lesions that simulate pulmonary 
nodules.  A 10 mm +100 HU lesion was placed in left upper lobe and a 12 mm +100 HU lesion 
was placed in the right middle lobe.  Lesion type and placement was based on the need to simulate 
a clinically relevant scenario and also take into account the complexity of the anatomical 
surroundings. This approach has been previous reported in the literature 19.  2) the CDRAD 2.0 
phantom (Artinis Medical System, The Netherlands)20. This phantom consists of a square acyclic 
plastic plate (265 x 265mm).  It is 10 mm thick and has holes of various depths and diameters 
providing a range of differently sized contrast details against a uniform background. Lungman was 
required for evaluating IQ and LV, while the CDRAD 2.0 phantom was required for evaluating 
LCD detectability.  Image acquisitions were undertaken using a commercially available X-ray 
machine (Wolverson X-Ray Ltd, Willenhall, West Midlands, UK) with an erect Bucky 
encompassing an anti-scatter radiation grid (10:1 ratio, 40 line/cm frequency) and 3 mm Al 
inherent X-ray beam filtration and a Konica Minolta Aero DR detector (Konica Minolta Medical 
Imaging USA INC, Wayne, NJ, USA).  Forty-two images of the Lungman phantom were acquired 
using a fixed 180 cm source to image receptor distance (SID), no additional filtration and manual 
exposure termination (fixed mAs).  Different settings of tube potential (70, 80, 90, 100, 110, 120 
and 130 kVp) and tube current-time (1, 2 and 3.2 mAs), with and without anti-scatter grids were 
applied during image acquisition. For all acquisitions the post-processing was determined as part 
of the imaging protocol and was based on a PA chest examination. Following this, 42 CDRAD 2.0 
phantom images were acquired using the same acquisition parameters that were applied to the 
Lungman phantom.  Each of the CDRAD 2.0 acquisitions were repeated three times as 
recommended by the CDRAD 2.0 phantom manufacturer20. The CDRAD 2.0 phantom was placed 
between 10 cm PMMA slabs to simulate an adult patient 21–23.  Acquisition parameters were 
selected to be similar to those used in clinical practice.  In addition, using manual exposure control 
together with an extremely wide range of acquisition factors allowed the acquisition of a series of 
images with a wide range of image qualities. The detector dose (without backscatter) was measured 
at the image detector surface using a solid-state dosimeter (RaySafe X2, Unfors RaySafe AB, 
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Billdal, Sweden), additionally the beam quality (half-value layer, HVL) for each kVp value was 
recorded using the same dosimeter (Appendix). 
Image quality evaluation 
LCD detectability from the CDRAD 2.0 phantom was represented by an IQFinv value, this was the 
average of the three repeated images and was produced automatically using the phantom analyser 
software20. The IQFinv was calculated using the following equation
20:-  
𝐼𝑄𝐹𝑖𝑛𝑣 =∑
1
𝐶𝑖𝑥𝐷(𝑖,𝑡ℎ)
15
𝑖=1
 
D(i, th) represents the lowest diameter (threshold diameter) in column (i) that has a visible hole 
correctly detected; Ci represents the depth value (contrast) of the object (visible hole) in the column 
(i).  Using the analyser software, the input parameters were set as follows; 1) the alpha level of 
significance was set at 1e-008, as recommended in the literature20, 24. 2) the priori difference of 
means was set relative to the image bit depth20, finally, SID was set to 180 cm.   
IQ and LV for the Lungman phantom images were evaluated visually by seven qualified diagnostic 
radiographers.  They applied a relative VGA method and a 5 point Likert scale (1= much worse ,2= 
worse ,3= equal ,4= better ,5=much better) using bespoke computer software 25 .The criteria used 
for IQ and LV evaluations are demonstrated in Tables 1 and 2, respectively and they are based on 
the European Guidelines 26 and the study by Ma et al. 27.  Two simulated lesions, in two different 
locations, as previously described were selected as shown in Figure 1.  For the relative VGA 
method, images were presented to observers on a computer monitor, on the left-hand monitor there 
was a fixed reference image and on the right hand monitor an image was randomly displayed from 
the experimental image bank.  Each observer reviewed the images using a 5 mega-pixel DOME 
E5 (NDSsi, Santa Rosa, CA) monitors (2048 by 2560 pixels), calibrated to the DICOM Grey Scale 
Display Function (GSDF) Standard 28,and applied the set of criteria whilst making a comparison 
against the reference image.  The reference image was selected by consensus opinion from expert 
observers since it had ‘average’ quality when compared with the others.  This was to ensure that 
all of the five points on the Likert scale points were used in the evaluations27, 29. Observers were 
not permitted to adjust the contrast, intensity or magnification of the image.  The overall IQ score 
for each image and for each observer was calculated by adding the scores from all of the IQ criteria.  
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This approach was similar for the calculations of overall LV, for each image, by each observer.  
Next, the final IQ score for each image was determined by taking the average IQ score across the 
seven observers, and the same method was used for LV.  Ethical approval for this study was 
granted from the University of Salford (HSR1617-76). 
 
 
Table 1. Visual image quality (IQ) criteria  26, 27. 
Item Criteria 
1 Demonstration of the vascular pattern in the whole lung, particularly 
the peripheral vessels. 
2 Visually sharp demonstration of the trachea and proximal bronchi. 
3 Visually sharp demonstration of the borders of the heart and aorta. 
4 Visually sharp demonstration of the diaphragm and lateral 
costo-phrenic angles. 
5 Visualisation of the retrocardiac lung and the mediastinum. 
6 Visualisation of the spine through the heart shadow. 
 
 
Table 2.  Simulated lesion visibility (LV) criteria27.  
Item Criteria 
1 Contrast of nodule, against background. 
2 Brightness of nodule, against background. 
3 Sharpness of nodule edge. 
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Figure 1. An example of a Lungman chest phantom image illustrating the two simulated lesions 
for the LV evaluation. (a) 10 mm +100 HU lesion placed in left upper lobe. (b) The 12 mm +100 
HU lesion was placed in the right middle lobe.  
Statistical analysis 
Data were analysed using SPSS version 22.0 (IBM Inc, Armonk, New York, US).  Data were first 
examined to investigate normality based on visual inspection of the data and the Shapiro-Wilk test.  
This was to determine the most appropriate correlation statistic between IQFinv and IQ and the LV.  
Data, which were normally distributed, were analysed using Pearson’s correlation coefficient; non-
parametric data were analysed using Spearman’s correlation coefficient. The interpretation of the 
strength of the correlation (r) was  conducted based on recommendations from the literature30, 31, 
in which r=0.1-0.29 (small), r=0.30-0.49 (medium), and r=0.50-1.0 (large).   
IQ and the IQFinv had a normal distribution whereas LV showed a non-parametric distribution. To 
investigate the inter-observer variability for the IQ and LV evaluations, an inter-class correlation 
coefficient (ICC) was utilised.  ICC values less than 0.5 indicate poor reliability, values from 0.5 
to 0.75 indicate moderate reliability, and values from 0.75 to 0.9 indicate good reliability finally 
values greater than 0.90 indicates excellent reliability32, 33. 
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3. Results 
The IQFinv values from the CDRAD 2.0 phantom images and visual IQ and LV evaluations, 
together with the acquisition parameters are illustrated in Table 3.  Correlation analysis between 
IQ and IQFinv demonstrated a strong positive correlation (r=0.91; p<0.001).  Spearman’s 
correlation was used to compare the IQFinv and LV.  A good correlation was observed for both 
lesions; lesion one (r=0.79; p<0.001); lesion two (r=0.68; p<0.001).  Figure 2 illustrates the linear 
regression curve between the IQ and IQFinv.  Figures 3 and 4 demonstrate the relationship, using 
a linear regression curve, between the LV for the first lesion and the second lesion again as a 
function of IQFinv.   
Excellent inter-observer agreement between the seven observers was observed (ICC=0.90; 95%CI: 
0. 84-0. 94) for the visual IQ evaluations. A good inter-observer agreement was observed for LV 
of the first lesion (ICC= 0.84; 95%CI: 0. 68-0. 90) and the second lesion (ICC=0.83; 95%CI: 0. 
714-0. 91)
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Table 3. Acquisition parameters used to acquire study images and the resultant mean and standard deviation (SD) of IQFinv, IQ and LV values. 
 
 
 
 
Mean (SD) IQFinv score 
Mean (SD) Relative VGA score 
LV IQ 
Left upper lobe Right middle lobe 
 1 2 3.2 1 2 3.2 1 2 3.2 1 2 3.2 
70 0.28(0.02) 0.40(0.07) 0.54(0.06) 6.43(2.15) 6.57(2.44) 7.00(2.36) 6.00(0.00) 6.00(1.13) 6.00(1.73) 12.14(1.57) 12.43(3.42) 12.71(4.00) 
80 0.79(0.07) 0.86(0.03) 1.00(0.09) 7.43(1.50) 6.86(2.27) 7.86(2.30) 6.29(1.81) 6.43(2.12) 7.57(1.95) 12.71(3.50) 12.71(3.45) 13.00(3.32) 
90 1.00(0.04) 0.59(0.06) 0.64(0.08) 7.57(2.16) 6.86(2.70) 8.43(2.65) 7.29(1.25) 6.1(1.81) 6.43(1.57) 13.43(3.55) 12.00(2.82) 12.71(3.26) 
100 0.89(0.05) 1.24(0.06) 1.21(0.08) 8.00(3.27) 8.71(1.25) 8.57(1.89) 7.0(2.07) 8.71(0.76) 9.00(0.00) 13.43(4.58) 14.43(3.02) 15.71(2.57) 
110 1.41(0.08) 1.57(0.10) 0.82(0.12) 8.29(1.46) 8.57(1.89) 8.57(2.79) 7.43(1.51) 9.00(0.00) 6.43(1.77) 17.43(1.51) 17.29(2.27) 12.71(3.82) 
120 1.17(0.03) 1.40(0.05) 1.45(0.11) 8.14(1.46) 8.57(1.27) 8.57(1.13) 8.00(2.15) 9.14(0.83) 9.00(0.00) 13.86(2.21) 17.14(2.34) 17.43(1.51) 
130 1.59(0.08) 1.84(0.18) 2.10(0.16) 9.00(1.00) 8.71(0.76) 8.86(0.90) 8.57(1.13) 8.00(1.41) 9.00(1.83) 17.86(0.38) 19.29(1.89) 18.57(1.62) 
70* 0.60(0.09) 0.74(0.04) 0.88(0.06) 10.00(2.63) 10.00(2.38) 9.57(3.76) 6.14(1.81) 8.00(1.53) 7.00(2.15) 12.43(3.26) 13.29(4.08) 13.43(3.64) 
80* 0.94(0.01) 1.15(0.11) 1.12(0.03) 9.86(1.77) 10.00(1.73) 9.71(2.06) 7.43(1.51) 8.29(2.91) 8.43(2.58) 13.71(3.41) 14.86(1.98) 14.86(1.86) 
90* 1.21(0.10) 0.97(0.04) 1.17(0.04) 10.57(1.62) 10.29(2.14) 10.29(1.70) 8.71(2.14) 8.57(2.45) 9.86(2.12) 14.71(1.98) 14.43(2.16) 14.86(1.68) 
100* 1.39(0.13) 1.68(0.13) 1.65(0.01) 10.29(2.51) 10.29(1.80) 10.14(2.04) 9.29(2.79) 9.43(1.72) 9.00(1.53) 15.86(1.35) 16.14(2.54) 18.00(2.83) 
110* 1.89(0.16) 1.75(0.05) 1.35(0.15) 10.00(2.70) 10.86(1.46) 10.14(1.86) 9.71(1.98) 9.29(3.00) 9.14(2.27) 16.14(2.04) 16.57(1.51) 15.43(2.51) 
120* 1.57(0.03) 1.88(0.12) 2.18(0.13) 10.29(1.72) 10.86(1.15) 10.71(2.00) 10.14(2.50) 8.86(1.68) 9.00(3.40) 16.57(0.98) 16.43(3.41) 16.43(2.57) 
130* 2.24(0.13) 2.39(0.12) 2.38(0.30) 10.43(1.40) 10.14(1.57) 11.29(1.40) 9.14(2.69) 9.00(3.87) 9.14(3.48) 19.14(3.24) 18.43(3.78) 19.00(2.89) 
Protocols indicated by a * were undertaken using an anti-scatter radiation grid.   
mAs 
kVp 
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Figure 2. Linear regression curve between mean IQFinv scores and mean IQ values.  Error bars 
across the x axis represent the SD of the scores between the seven observers, while the error bars 
across the y axis represents the SD from the three automated CDRAD 2.0 image scores. 
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Figure 3. Linear regression curve between the mean IQFinv scores against the mean LV scores for 
the first lesion (left upper lobe).  Error bars across the x axis represent the SD of the scores between 
the seven observers, while the error bars across the y axis represents the SD of the three CDRAD 
2.0 image scores. 
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Figure 4. Linear regression curve between the mean IQFinv scores against the mean LV scores 
for the second lesion (right middle lobe).  Error bars across the x axis represent the SD of the 
scores between the seven observers, while the error bars across the y axis represents the SD of 
the three CDRAD 2.0 image scores. 
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4. Discussion 
Image quality and lesion visibility studies have a number of applications within medical imaging 
but are notoriously labour intensive. Automated methods for evaluating IQ are attractive but 
historically there has been a lack of data on their relationships with perceptual (visual) methods.  
It must be acknowledged that there are potential limitations when using the CDRAD phantom for 
IQ evaluation and CXR optimisation studies.  The chest region is classified as a quantum-saturated 
region where the anatomical structures are the main factor that influence lesion detection and IQ 
when compared with quantum noise 34. Quantum noise is a limiting factor for physics phantoms 
(i.e. CDRAD 2.0) whereas images acquired on patients would be limited by anatomical noise. 
Results from our study have demonstrated a strong positive correlation (r=0.91; p<0.001) between 
the physical evaluation of LCD detectability (IQFinv from the CDRAD 2.0 phantom) and IQ 
evaluations from Lungman.  Based on IQ alone, the CDRAD 2.0 phantom appears to be a valid 
and a well justified approach and can be used as a surrogate for IQ tasks using an anthropomorphic 
phantom when evaluating the performance of radiography systems or during optimisation studies.  
For LV, it is important to know to what extent there is correlation between the IQFinv values and 
LV from the Lungman phantom images since the CDRAD 2.0 phantom was designed to examine 
the performance of imaging systems in visualising LCD objects. 
Our findings demonstrated a good positive correlation between IQFinv and LV for the two 
simulated lesions; the first lesion showed r=0.79 (p<0.001) and the second lesion showed r=0.68 
(p<0.001).  It was useful to examine the correlation between the IQFinv and the LV when the lesions 
were located in different positions and with different levels of visibility (high and low).  This was 
necessary to understand how the variations in the location and visualisation of the lesion affect the 
correlation values of IQFinv. Although the two simulated lesions have the same HU value (+100 
HU), the radiographic visibility of the first simulated lesion (in the left upper lobe) was lower than 
that of the second one (in the right middle lobe). This is related to the complexity of the anatomical 
background surrounding the first simulated lesion.  A relatively large part of this simulated lesion 
is covered by the first anterior rib and third posterior rib and the HU values for the surrounding 
lung, the first anterior rib and the third posterior rib were -890, 353 and 575, respectively. In 
contrast, a small part of the second simulated lesion is covered by the fourth anterior rib.  The HU 
values for the surrounding lung and the fourth anterior rib were -1027 and 467, respectively 
(Figure 1). In addition, the first simulated lesion had a smaller diameter (10 mm) compared with 
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that of the second simulated lesion (12 mm). It was found that the lesion with lower visibility (left 
upper lobe) had higher correlation (r=0.79) when compared with that of the higher visibility lesion 
(right middle lobe, r=0.68). A possible reason behind this could be because the small levels of 
improvement and degradation of general IQ which would have a higher impact on increasing or 
decreasing the visualisation of the lower visibility lesion when compared with that of the higher 
visibility lesion (acquisition parameters had more of an effect on the lower visibility lesion).  The 
good positive correlation observed under these two conditions provides a useful indication on the 
utility of the CDRAD 2.0 phantom for investigating the performance of an imaging system in LCD 
detection. 
To our knowledge, only one study undertaken by De Crop and colleagues, attempted to investigate 
the correlation between the LCD detectability using a CDRAD 2.0 phantom and IQ from cadaveric 
images using an absolute VGA method21.  However, the correlation between LV and LCD 
detectability from CDRAD 2.0 has not been investigated.  Within the work of De Crop et al.21 
comparable results were reported with a strong positive correlation (r=0.91; p=0.001) between the 
physical evaluation of IQFinv (CDRAD 2.0) and IQ (cadavers).  Our work has built upon the study 
by De Crop et al.36 in that we used a Lungman phantom loaded with simulated pulmonary lesions 
instead of three normal cadavers with no inherent pathology.  The inclusion of pathology provides 
the opportunity for a more accurate evaluation of IQ and the detection task, and it is an important 
factor in optimisation studies.  We consider our study to have some methodological benefits when 
compared with De Crop et al.36  Within our work a wider range of image qualities were generated 
and tested compared with that by De Crop et al.36, this can be seen from the lowest value of IQFinv 
in our study which was equal to 0.28 compared with 2.56 in study by De Crop et al.  The range of 
image qualities generated in our study closely reflected those acquired in clinical practice but also 
included both high (IQFinv =2.39) and low (IQFinv =0.28) qualities, this was necessary to ensure 
that the correlations between the IQFinv and IQ / LV were tested across a full range of different 
levels of IQ. Image qualities in our study were deemed similar to those acquired in clinical practice 
for several reasons. First, a group of experienced radiographers were asked to provide acquisition 
parameters routinely used within their clinical practice. Second, acquisitions parameters were 
compared with those cited within the literature. Third, resultant images were reviewed by a group 
of experts and were deemed to demonstrate a range of image qualities which may be expected 
within the clinical environment. We also used a relative VGA method, without allowing 
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windowing and magnification.  This was different to the absolute VGA system, with windowing 
and magnification, used in the study by De Crop et al.36  Utilising a relative VGA approach is 
justified because it is likely to be less biased and more sensitive in detection of subtle variations in 
image quality, this is due to the presence of a reference image. Although the free adjustment of 
image viewing parameters, such as brightness, contrast and magnification are considered part of a 
clinical review of an image, it could, however, influence the correlation between the IQFinv and 
the IQ and LV and was not permitted within this study. A consistent image display is necessary to 
ensure that any measured variation in IQ results only from the imaged object and not the 
adjustment of image viewing parameters such as zooming or windowing.  
Geijer et al.35 investigated the influence of different tube potentials (by adjusting the mAs values 
to keep the effective dose constant) on IQ in lumbar spine radiography using two different 
phantoms, CDRAD 2.0 and the adult anthropomorphic Alderson phantom.  Findings of the study 
by Geijer et al. 35 demonstrate that the IQ was higher for high kVp values (≥96 kVp) for both 
phantoms.  Bacher et al.23 compared the performance of an amorphous silicon and amorphous 
selenium flat-panel detector using two different approaches: clinical images generated from 
patients and using CDRAD 2.0 phantom images.  Both methods showed that the amorphous silicon 
flat-panel system had a lower effective dose, without any reduction of IQ when compared with 
that of amorphous selenium flat-panel system.  However, in these two studies the correlation 
between the IQ from the Alderson phantom, images from patients and the IQFinv from the CDRAD 
2.0 phantom were not calculated. Within mammography, the use of the CDMAM phantom is well 
established36–38 and there is some similarity in the evaluation of image quality with CDMAM and 
the methods described in this study.  To our knowledge, there is no study which has investigated 
the correlation between the IQFinv and the LV, as a result there is no data available in the literature 
to compare with our findings.  The good positive correlations reported in our study (IQFinv and IQ 
and LV) might also have a value in indicating the detectability of abnormality and possibly this 
could extend to lesion detection performance; several studies have found that there is a correlation 
between pathological detectability and the visibility of normal anatomical structure39–42. 
In 2011, Moore et al. 43 created and validated a computer algorithm which was able to simulate 
computed radiography (CR) chest images from digitally reconstructed radiographs (DRRs) 
generated by ray tracing virtual X-rays through clinical patient CT datasets. Several studies have 
been conducted by Moore et al. 44, 45 that focused on optimisation of CR CXR imaging using a 
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DRR computer simulation. The simulated clinical experiment (simulated DRR) used by Moore et 
al. has been successfully utilised for deriving an optimal exposure parameter for CXR 
examinations. Therefore, further studies could be conducted using DRRs or clinical images from 
patients, applying the same acquisition parameters used in our study, to investigate the validity of 
using the CDRAD 2.0 phantom as a measure of clinical image quality in optimisation studies. This 
can provide a further evidence of the validity of using the CDRAD phantom for optimisation 
studies. 
 Also, based on our findings, future work could focus on establishing a baseline IQFinv value for 
CXR that identifies the threshold of LCD detectability that is required for obtaining an adequate 
IQ for diagnosis.  The availability of such baseline measures is highly beneficial for routine quality 
assurance programs to ensure that the IQ is within accepted limits, and it is also beneficial for 
optimisation studies as it can facilitate the evaluation of how different techniques can influence IQ 
in clinical practice. 
A limitation of our study was that the correlations between the LCD detectability and IQ and LV 
were only carried out using a standard size anthropomorphic phantom and the variation in phantom 
size were not taken into account. Anatomical noise would increase for larger patients and it was 
not possible to assess the effects of this within our study. A further limitation was the correlation 
between the LCD detectability and the LV was carried out using only one type of simulated lesions 
(that simulate a pulmonary nodules) and the other types (such as micronodules, lines, and reticular 
opacities) were not considered. Future work can be undertaken taking into account these 
limitations by using different anthropomorphic phantom sizes, loaded with different simulated 
lesions. 
  5. Conclusion 
Based on our findings, there is an excellent correlation between LCD detectability using CDRAD 
2.0 phantom and IQ.  A good correlation existed between LCD detectability and LV. It can be 
confirmed that the CDRAD 2.0 phantom is valid for evaluating IQ and LV and could be of use in 
digital CXR optimisation studies.  Also, our findings suggest it is possible that the CDRAD 2.0 
phantom can be utilised along with the automated evaluation method for LCD detectability within 
routine quality assurance and optimisation studies. 
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Appendix: 
 
Detector dose values during imaging CDRAD 2.0 and Lungman phantoms and the values of HVL corresponding for each kVp value.   
 
Image 
number 
kVp mAs Grid Detector Dose (µG) 
(CDRAD phantom) 
Detector Dose (µG) 
(Lungman phantom) 
HVL 
1,2,3 70 1 2 3.2 No 0.79 2.04 3.59 0.35 0.95 1.68 3.46 
4,5,6 80 1 2 3.2 No 1.29 3.30 5.65 0.59 1.56 2.71 3.96 
7,8,9 90 1 2 3.2 No 1.94 4.80 8.20 0.91 2.30 4.01 4.34 
10,11,12 100 1 2 3.2 No 2.66 6.51 11.19 1.29 3.12 5.48 4.79 
13,14,15 110 1 2 3.2 No 3.46 8.47 14.55 2.12 4.52 7.24 5.25 
16,17,18 120 1 2 3.2 No 4.65 10.60 17.82 2.66 5.55 8.97 5.63 
19,20,21 130 1 2 3.2 No 5.65 13.16 22.28 3.29 6.83 11.05 5.87 
22,23,24 70 1 2 3.2 Yes 0.13 0.30 0.50 0.07 0.18 0.28 3.46 
25,26,27 80 1 2 3.2 Yes 0.24 0.53 0.85 0.14 0.32 0.51 3.96 
28,29,30 90 1 2 3.2 Yes 0.38 0.82 1.32 0.24 0.51 0.82 4.34 
31,32,33 100 1 2 3.2 Yes 0.54 1.18 1.89 0.35 0.76 1.20 4.79 
34,35,36 110 1 2 3.2 Yes 0.79 1.61 2.59 0.49 1.05 1.73 5.25 
37,38,39 120 1 2 3.2 Yes 0.99 2.06 3.37 0.67 1.39 2.23 5.63 
40,41,42 130 1 2 3.2 Yes 1.24 2.69 4.40 0.86 1.82 2.97 5.87 
 
 
